M Tiittanen, JT Huupponen, M Knip, O … - Diabetes, 2006 - Am Diabetes Assoc Patients with type 1 diabetes are treated with daily injections of human
insulin, an autoantigen expressed in thymus. Natural CD4+CD25 high regulatory
T-cells are derived from thymus, and accordingly human insulin–specific ... Cited by 18 - Related articles - BL Direct - All 6 versions
A Kivling, L Nilsson, K Fälth-Magnusson, S … - System, 1927 - interscience.wiley.com Imbalance between different types of T lymphocytes, such as T helper (Th) and
regulatory T cells (Tregs), has been reported to play a part in the pathogenesis
behind such autoimmune diseases as type 1 diabetes (T1D) and celiac disease ... Cited by 2 - Related articles - All 4 versions
CA TABOR, EC PARLETTE - Postgraduate medicine, 2006 - cat.inist.fr PREVIEW Diabetes attacks multiple organ systems, and the skin is not spared its
detrimental effects. Pathologic consequences of diabetes, such as vasculopathy,
neuropathy, immunologic disturbances, defects in collagen formation, and ... Cited by 3 - Related articles - BL Direct - All 2 versions
MC Foss-Freitas, NT Foss, EA Donadi, MC … - Sao Paulo Medical Journal, 2006 - SciELO Brasil Key words: Cell culture. Lymphocyte transformation. Type I diabetes mellitus.
Type II diabetes mellitus. Hyperglycemia. Infection. ... CONTEXTO E OBJETIVO:
Diabetes mellitus é uma síndrome clínica que freqüentemente leva ao ... Cited by 4 - Related articles - Cached - All 2 versions
J Grant, K Bourcier, S Wallace, D Pan, A … - Cytometry B Clin Cytom, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 5 - Related articles - All 2 versions
V Seyfert-Margolis, TD Gisler, AL Asare, RS … - Diabetes, 2006 - Am Diabetes Assoc Type 1 diabetes is a chronic autoimmune disease mediated by autoreactive
T-cells. Several experimental therapies targeting T-cells are in clinical
trials. To understand how these therapies affect T-cell responses in vivo, ... Cited by 19 - Related articles - BL Direct - All 8 versions
- ►jimmunol.org D Hawiger, E Tran, W Du, CJ Booth, L Wen, C … - The Journal of Immunology, 2008 - Am Assoc Immnol Initiation of diabetes in NOD mice can be mediated by the costimulatory signals
received by T cells. The ICOS is found on Ag-experienced T cells where it acts
as a potent regulator of T cell responses. To determine the function of ... Cited by 7 - Related articles - All 2 versions
G Szalai, V Fellegi, Z Szabo, LC Vitez - ANNALS-NEW YORK ACADEMY OF SCIENCES, 2006 - interscience.wiley.com Abstract: Fungal sinusitis caused by invasive fungal infections, such as
Mucormycosis, occurs predominantly in an immunocompromised patient. However,
invasive cranial bone mycoses are rare and are usually associated with host ... Cited by 7 - Related articles - BL Direct - All 5 versions
MC Foss-Freitas, NT Foss, EA Donadi, MC … - ANNALS-NEW YORK ACADEMY OF SCIENCES, 2006 - interscience.wiley.com Abstract: Tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels were
evaluated in lipopolysaccharide (LPS)-stimulated cell cultured monocytes
obtained from 24 type 1 and type 2 diabetic patients presenting inadequate ... Cited by 8 - Related articles - BL Direct - All 4 versions
EM Schmidt, CJ Wang, GA Ryan, LE Clough, … - The Journal of Immunology, 2009 - Am Assoc Immnol The CTLA-4 pathway is recognized as a major immune inhibitory axis and is a key
therapeutic target for augmenting antitumor immunity or curbing autoimmunity.
CTLA-4-deficient mice provide the archetypal example of dysregulated immune ... Cited by 8 - Related articles - All 2 versions
